SyringolCAS# 91-10-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 91-10-1 | SDF | Download SDF |
PubChem ID | 7041 | Appearance | Oil |
Formula | C8H10O3 | M.Wt | 154.2 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2,6-dimethoxyphenol | ||
SMILES | COC1=C(C(=CC=C1)OC)O | ||
Standard InChIKey | KLIDCXVFHGNTTM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H10O3/c1-10-6-4-3-5-7(11-2)8(6)9/h3-5,9H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Syringol and phenol have modifying effect on NMOR formation in vivo to be similar, the effect of food on NMOR levels in blood is more important than that of the modifiers. |
Syringol Dilution Calculator
Syringol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.4851 mL | 32.4254 mL | 64.8508 mL | 129.7017 mL | 162.1271 mL |
5 mM | 1.297 mL | 6.4851 mL | 12.9702 mL | 25.9403 mL | 32.4254 mL |
10 mM | 0.6485 mL | 3.2425 mL | 6.4851 mL | 12.9702 mL | 16.2127 mL |
50 mM | 0.1297 mL | 0.6485 mL | 1.297 mL | 2.594 mL | 3.2425 mL |
100 mM | 0.0649 mL | 0.3243 mL | 0.6485 mL | 1.297 mL | 1.6213 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2,6-Bis(hydroxymethyl)-p-cresol
Catalog No.:BCC8505
CAS No.:91-04-3
- 2-Benzoylpyridine
Catalog No.:BCC8562
CAS No.:91-02-1
- 8-Methoxybonducellin
Catalog No.:BCN4453
CAS No.:90996-27-3
- A 83-01
Catalog No.:BCC1319
CAS No.:909910-43-6
- W146
Catalog No.:BCC7723
CAS No.:909725-61-7
- α-CGRP (human)
Catalog No.:BCC5962
CAS No.:90954-53-3
- Cl-HIBO
Catalog No.:BCC7147
CAS No.:909400-43-7
- Erythrocentauric acid
Catalog No.:BCN7683
CAS No.:90921-13-4
- Broussonin E
Catalog No.:BCN4452
CAS No.:90902-21-9
- M871
Catalog No.:BCC5930
CAS No.:908844-75-7
- α-helical CRF 9-41
Catalog No.:BCC5727
CAS No.:90880-23-2
- Aprotinin
Catalog No.:BCC1220
CAS No.:9087-70-1
- Coumarin
Catalog No.:BCN6309
CAS No.:91-64-5
- Benzoguanamine
Catalog No.:BCC8853
CAS No.:91-76-9
- N,N'-Bis(acetoacetyl)-o-toluidine
Catalog No.:BCC9062
CAS No.:91-96-3
- Fmoc-Arg-OH
Catalog No.:BCC3039
CAS No.:91000-69-0
- Impurity of Calcipotriol
Catalog No.:BCC5388
CAS No.:910133-69-6
- CGI-1746
Catalog No.:BCC1473
CAS No.:910232-84-7
- RGDS peptide
Catalog No.:BCC7694
CAS No.:91037-65-9
- BAY 60-6583
Catalog No.:BCC6197
CAS No.:910487-58-0
- Danshenol C
Catalog No.:BCN6681
CAS No.:910856-25-6
- 8-Epidiosbulbin E acetate
Catalog No.:BCN7812
CAS No.:91095-48-6
- 3,6,19,23-Tetrahydroxy-12-ursen-28-oic acid
Catalog No.:BCN1310
CAS No.:91095-51-1
- Furowanin A
Catalog No.:BCN4790
CAS No.:911004-72-3
Ultraviolet spectroscopy of fundamental lignin subunits: guaiacol, 4-methylguaiacol, syringol, and 4-methylsyringol.[Pubmed:24116625]
J Chem Phys. 2013 Oct 14;139(14):144313.
Ultraviolet spectroscopy of the G- and S-type lignin subunits, guaiacol (G) and Syringol (S), along with their para-methylated derivatives 4-methylguaiacol (4-MG) and 4-methylSyringol (4-MS), has been carried out in the cold, isolated environment of a supersonic jet. The excitation spectra and dispersed fluorescence (DFL) spectra of G and 4-MG show strong S0-S1 origins and Franck-Condon activity involving both the ring modes typical of aromatic derivatives, and the four lowest frequency out-of-plane modes (a") and lowest in-plane mode (a') involving the OH and OCH3 groups. The four low-frequency out-of-plane modes undergo extensive Duschinsky mixing between the ground and excited state. In 4-MG, combination bands involving methyl rotor levels with out-of-plane modes appeared with surprisingly high intensity, indicating a high degree of hindered rotor-vibration coupling in both S0 and S1. These mixing effects accompany the change in geometry upon pi-pi * electronic excitation going from a planar ground state to a non-planar excited state. Time-dependent density functional theory (TDDFT M05-2X6-311++G(d,p)) calculations predict a geometric distortion along the out-of-plane oxygen flapping coordinate, yielding a double minimum potential in S1 with a barrier to planarity of 195 cm(-1) in G. The excitation spectrum of S and 4-MS showed a much higher degree of spectral congestion and a larger geometry change evident by a shifted intensity distribution peaking approximately 300 cm(-1) above the electronic origin. TDDFT calculations predict a larger geometry change in S compared with G, with the OH and H-bonded methoxy groups displaced in opposite directions abovebelow the ring plane. Dispersed fluorescence from all S1 excited state levels in S4-MS yield only broad emission peaking far to the red of the excitation wavelength (-4500 cm(-1)). Several hypotheses regarding the source of this broad, redshifted emission were tested, but the cause remains unclear. p-Methylation was found to significantly redshift the UV absorption in both 4-MG and 4-MS, and methyl rotor transitions were assigned in both allowing for the determination of the shape and barrier heights of their respective potentials. These results provide a foundation for the discrimination of G- and S-chromophores in lignin oligomers, and demonstrate the potential for site-selective absorption.
Effects of phenol and 2,6-dimethoxyphenol (syringol) on in vivo formation of N-nitrosomorpholine in rats.[Pubmed:3708751]
Carcinogenesis. 1986 Jun;7(6):867-70.
We determined the effects of phenol and 2,6-dimethoxyphenol (Syringol) on N-nitrosomorpholine (NMOR) formation in rats given morpholine and nitrite by gavage. At 30 min post-gavage the recovery (from the stomach, duodenum and blood) of 564 micrograms NMOR was six times higher when administered to rats by gavage with 2 g of semipurified diet (SPD) than when given without food. Rats were gavaged with 12 mg each of morpholine, one of the modifiers and nitrite and examined 30 min later. Syringol decreased the amount of NMOR in both the stomach and blood by 89%, while phenol had no effect. We compared these results with those obtained with ascorbic acid and thiocyanate. The effect of ascorbic acid was similar to that of Syringol. However, thiocyanate increased the amount of NMOR in the stomach and blood 2.7- and 4-fold, respectively. When 2 g of SPD was administered to rats by gavage, together with the precursors, Syringol and ascorbic acid blocked NMOR formation in the stomach by 58 and 45%, respectively, and thiocyanate enhanced the yield 1.5-fold. The effect of phenol was not significant for the stomach and blood and that of the other modifiers was not significant for blood. Administration of the reactants together with food decreased the NMOR level in blood 155-fold relative to controls (no food), suggesting that food decreased the absorption rate over a 30-min period. These results demonstrate the modifying effect of phenol and Syringol on NMOR formation in vivo to be similar to that observed in a previous in vitro study, and show that the effect of food on NMOR levels in blood was more important than that of the modifiers.